Collplant Biotechnologies Ltd ADR (CLGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2017 | 12-2016 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | N/A | 1,076 |
| Receivables | N/A | 1,072 |
| Inventories | N/A | 138 |
| TOTAL | $N/A | $2,286 |
| Non-Current Assets | ||
| Other Non-Current Assets | 0 | 206 |
| TOTAL | $N/A | $206 |
| Total Assets | $N/A | $4,090 |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 0 | 1,471 |
| Other current liabilities | N/A | 458 |
| TOTAL | $N/A | $1,929 |
| Non-Current Liabilities | ||
| Long Term Debt | N/A | 81 |
| Other Non-Current Liabilities | 0 | 618 |
| TOTAL | $N/A | $699 |
| Total Liabilities | $N/A | $2,628 |
| Shareholders' Equity | ||
| Common Shares | N/A | 909 |
| Retained earnings | N/A | -44,747 |
| TOTAL | $N/A | $1,462 |
| Total Liabilities And Equity | $0 | $4,090 |